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Abstract 
 
Objectives 
Proper valve selection is critical to ensure appropriate valve replacement for patients, 
because implantation of a small valve might place the patient at risk for persistent 
gradients. Labeled valve size is not the same as millimeter measure of prosthetic valve 
diameters or the annulus into which it will fit. Studies that use the labeled valve size in 
lieu of actual measured diameter in millimeters to compare different valves might be 
misleading. Using human cadaver hearts, we sized the aortic annulus with 8 commonly 
used prosthetic aortic valve sizers and compared the valves using geometric orifice area. 
This novel method for comparing prosthetic valves allowed us to evaluate multiple valves 
for implantation into the same annulus. 
Methods 
Aortic annular area was determined in 66 cadavers. Valve sizers for 8 prosthetic valves 
were used to determine the appropriate valve for aortic valve replacement. Regression 
analyses were performed to compare the relationship between geometric orifice area and 
aortic annular area. 
Results 
Tissue valves had a larger orifice area for any annular size but were not different at small 
sizes. Supra-annular valves were larger than intra-annular valves for the small annulus, 
but this relationship was not uniform with increasing annular size. 
Conclusions 
Labeled valve size relates unpredictably to annular size and orifice area. No advantage in 
geometric orifice area could be demonstrated between these tissue valves at small annular 
sizes. Valves with the steepest slope on regression analysis might provide a larger benefit 
with upsizing with respect to geometric orifice area. 
 
Abbreviations: AVR, aortic valve replacement; EOA, effective orifice area; GOA, 
geometric orifice area 
 
------------------------------------------------------- 
 
Valve selection is critical to ensure appropriate valve replacement for a given patient, 
because implantation of a valve that is too small places the patient at risk for persistent 
gradients.1, 2, 3, 4, 5 and 6 
 
Labeled valve size is not the same as a millimeter measure of the prosthetic valve 
diameter or the aortic annulus into which it will fit.7, 8, 9, 10 and 11 Valve sizers are made 
slightly larger than the corresponding valve to avoid problems seating the valve after 
sutures have been placed. Studies that use the labeled valve size in lieu of the actual 
measured diameter in millimeters to compare different valves might be misleading.7 
Furthermore, there is some small variability in the construction of these valves that 
further adds to the difficulty in comparing different products. 
 
A standard sizer that gives the actual measurement of the aortic annulus in calibrated 1-
mm increments is not used in general practice. After echocardiographic estimation of 
valve size, the surgeon evaluates the aortic annulus in the operating room using sizers 
provided by the manufacturers. These manufacturer-provided sizers do not always share 
the shape of the aortic annulus or the prosthesis to be inserted and are intentionally made 
slightly larger than the corresponding valve to avoid problems with implantation once 
sutures have been placed. These factors can lead to implantation of a valve that might be 
inadequate to relieve valvular stenosis in the small aortic root, despite a labeled valve size 
that would indicate otherwise. 
 
Patients with a small aortic root carry a risk of patient-prosthesis mismatch.1 A larger 
valve can be placed into a small aortic root by performing an aortic root enlargement 
procedure.12 and 13 However, this might increase operative mortality.14 Although the 
clinical relevance of patient-prosthesis mismatch remains controversial,15, 16 and 17 a small 
valve might not completely relieve aortic stenosis, might maintain increased left 
ventricular workload, and might contribute to adverse patient outcomes.2, 3, 4 and 5 
Using human cadaver hearts, we sized the aortic annulus for aortic valve replacement 
(AVR) with 8 commonly used prosthetic aortic valves and compared the valves on the 
basis of geometric orifice area (GOA). This novel method for comparing prosthetic 
valves allowed multiple valves to be evaluated on the same annulus. 
 
Materials and Methods 
 
Between January 1 and September 30, 2005, all deaths referred to the medical examiner 
in our institution were evaluated for the study. Cadavers were excluded from the study 
for previous valve surgery, assist device implantation, heart transplantation, advanced 
decay, or a delay of 2 hours or more after the heart was removed from the body. 
Postmortem examinations were performed by a pathologist and mortician in the 
department of pathology at our institution. The heart was removed from the chest and 
submerged in a cool bath until examination. 
 
The heart was placed in a container, and the aorta was transected 2 cm above the 
sinotubular junction. The aorta was then transected just above the ostia of the coronary 
arteries in a horizontal plane. The degree of calcification of the aorta, the aortic valve 
cusps, and the aortic annulus was assessed. After removal of the valve cusps, the annulus 
was measured with cylindrical plastic sizers with 1-mm increments (standard sizer) to 
record true annular size. The annulus was defined as the narrowest area associated with 
the aortic root after removal of the cusps. Valve sizers corresponding to the 8 valves were 
then used to size each valve according to the instructions for use provided by the 
manufacturers. The corresponding valve size was then recorded, as appropriate, for AVR. 
After these measurements were taken, a postexperimental measurement using the 
standard sizer was taken to evaluate for annular stretch. 
 
The valves in this study were 5 mechanical valves, including the CarboMedics Standard 
and Top Hat (CarboMedics, Austin, Tex), the ATS AP (ATS Medical, Minneapolis, 
Minn), and the St Jude Standard and Regent (St Jude Medical, St Paul, Minn), and 3 
stented tissue valves, including the Carpentier–Edwards Perimount Pericardial Model 
2700 and Perimount Magna Model 3000 (Edwards Lifescience, Irvine, Calif) and the 
Medtronic Mosaic Model 305 (Medtronic, Minneapolis, Minn). The Carbomedics Top 
Hat, ATS AP, and St Jude Regent valves are manufactured to be placed in a supra-
annular position. The CarboMedics and St Jude Standard valves are designed for intra-
annular placement. 
 
The GOA of each valve was used for analysis by using values for GOA that were 
acquired from each company. Deviation of the labeled valve size from the measured 
annular size by using the standard sizer was calculated and analyzed with a paired t test. 
The relationship between GOA and measured annular size in each valve was analyzed by 
means of linear regression (PSI-Plot, Pearl River, NY). The data for the Carbomedics 
Top Hat for measured annular areas of 5.72 cm2 (diameter, 27 mm) or larger was not 
included in the analysis because the largest available size is 27 (4 subjects were excluded 
from the analysis). 
 
Results 
 
A total of 66 cadaver hearts (33 male and 33 female cadavers with a mean age of 65 ± 16 
years) were studied (Table 1). Distribution of patients across measured annular size is 
shown in Figure 1. Deviation of the labeled valve size from the measured annular 
diameter is shown in Figure 2 for both mechanical valves (top) and bioprosthetic valves 
(bottom). Mechanical valves had significant differences in the labeled valve size from the 
measured annular diameter when comparing the products from different companies. 
(Figure 2, top). All mechanical valves except the CarboMedics Top Hat had labeled valve 
sizes smaller than the measured annular diameter into which that valve could be placed. 
All labeled valve sizes were statistically different from one another, with the exception of 
the relationship between the St Jude Standard and Regent (−0.59 ± 1.14 and −0.71 ± 1.30 
cm, respectively). The 3 stented bioprosthetic valves demonstrated greater parity with the 
measured annular diameter than the mechanical valves (Figure 2, bottom). There was a 
small but significant difference between the Edwards Pericardial and the Magna (P = 
.017). 
 
Twenty-nine percent (19/66) of the specimens had an increase in annular size, as 
measured before and after the experimental protocol. There was a small but significant 
difference between average pre-experimental and postexperimental measured annular 
size (24.3 ± 2.3 and 24.6 ± 2.3 mm diameter, respectively, P = .00003, and 4.68 ± 0.904 
and 4.78 ± 0.903 cm2 area, respectively, P = .00004). 
 
Grouping valves by type and implantation position, the bioprosthetic valves had a larger 
GOA compared with that of the supra-annular mechanical valves, which had larger 
GOAs than those of the intra-annular mechanical valves (Figure 3). Regression equations 
for each prosthetic valve showing measured annular area versus GOA are shown in 
Figure 4 and Figure 5. The data for measured annular sizes of greater than 27 mm were 
not included in the analysis for the CarboMedics Top Hat because the largest labeled 
valve size is 27, and therefore there would be no increase in GOA beyond 27 for the Top 
Hat, which would inappropriately skew the data. 
 
There was no difference in GOA demonstrated for the 3 bioprosthetic valves in the small 
annular sizes (area, 2.83–3.46 cm2; diameter, 19–21 mm). With increasing size, the 
Magna had the greatest increase in GOA relative to measured annular area, translating 
into the steepest slope compared with the others. The Magna was followed by the 
Pericardial and then the Mosaic. 
 
The intra-annular mechanical valves (CarboMedics and St Jude Standard valves) had 
nearly the same regression line. For the supra-annular valves, the St Jude Regent was 
larger than both the ATS AP and the CarboMedics Top Hat at smaller sizes. There was 
no difference between the AP and the Top Hat at the smaller sizes, but the ATS AP had 
the steepest slope on regression analysis. 
 
Discussion 
 
Inconsistency of labeled valve sizes has been well documented and might contribute to 
misinformation and confusion.7, 8 and 9 In the worst-case scenario, patient-prosthesis 
mismatch1 will occur and result in adverse patient outcomes.2, 3, 4 and 5] 
We used a novel method to compare prosthetic valves by using cadaver hearts as a 
surrogate for live human hearts. One difference in a cadaver heart compared with a 
patient undergoing AVR is the degree of aortic and valvular disease. In our study only a 
small number of patients had a similar degree of calcification compared with patients 
undergoing AVR for aortic stenosis (Table 1). However, a well-debrided aortic annulus 
should be similar to a normal cadaver annulus, making this a feasible model. This study 
could not be conducted in living subjects because of the potential for injury. Multiple 
passes with valve sizers and time added to an operation in which a patient is on 
cardiopulmonary bypass with the aorta crossclamped raise obvious ethical concerns. 
 
We sized the same aorta for every valve and used GOA to compare the valves, thereby 
removing the labeled valve size and hemodynamic variability from the comparison. GOA 
is a measure of the area of flow based on the internal diameter of a valve and is an 
appropriate tool for comparison between valves. Unlike effective orifice area (EOA), 
GOA does not require complex hemodynamic measurements and calculations that have 
inherent variability related to heart rate, blood pressure, ejection fraction, and 
echocardiographer variability. However, GOA does not take into account obstruction to 
flow caused by the leaflets in the bioprosthetic valves or the leaflet suspension apparatus, 
resistance to leaflet movement, and opening angle in the mechanical valves. The 
advantage of using GOA for analysis is that it allows for comparison between valves with 
a measurement that is reproducible and neither operator dependent nor hemodynamically 
variable. Large retrospective series studying orifice size18 and others looking at EOA6 and 
19
 have been conducted with results that do not demonstrate the superiority of one 
measurement methodology over the other. Multiple trials with EOA have shown that the 
incidence of echocardiographically determined patient–prosthesis mismatch is quite 
variable, estimated by Pibarot and Dumesnil20 in a recent review to be 20% to 70%. This 
variability might, in itself, be due to the inherent variability in measuring EOA in patients 
who could actually have clinically similar orifice areas from a prosthetic valve.21 
 
Implantability of prosthetic valves is multifactorial. Patient morphology, including the 
size of the aorta, sinotubular junction, and degree of calcification, is highly variable. A 
less pliable calcified aorta might not have enough flexibility to allow placement of an 
optimally sized valve in the appropriate position. This could require either undersizing 
the valve to get it seated on the annulus or performing an aortic root enlargement 
procedure. These choices place the patient at increased risk for patient-prosthesis 
mismatch on the one hand and increased morbidity and mortality from additional surgical 
intervention on the other.12, 13 and 14 
 
Our study demonstrates that the manufacturer-labeled valve size does not predictably 
correspond to the size of the annulus into which the valve will fit. This makes 
comparisons on the basis of labeled valve size alone inappropriate and further reinforces 
the need for standardization in sizing. 
 
These data do not demonstrate an advantage in GOA of one bioprosthetic valve over 
another at smaller sizes. This is of interest considering that the GOAs of the Pericardial 
and the Magna are the same, and the external diameter differences are in the construction 
of the sewing ring, resulting in a smaller external diameter for the Magna. This is similar 
to the CarboMedics Standard and Top Hat, except that these 2 valves are significantly 
different in construction and have very different sizers, explaining the results in this 
study. 
 
The intra-annular mechanical valves were essentially the same, and the supra-annular 
valves always had larger GOAs at the smaller sizes, with more variability at the larger 
sizes. Differences in GOA between the supra-annular valves and the intra-annular valves 
support the use of supra-annular valves to maximize GOA in patients with a small aortic 
annulus. The larger GOA of the bioprosthetic valves as a whole over the supra-annular 
mechanical valves could also be exploited in patients at high risk for patient-prosthesis 
mismatch. 
 
The data support the superiority in GOA of the St Jude Regent valve at smaller annular 
sizes. We did not demonstrate a difference between the ATS AP and the CarboMedics 
Top Hat valves at small sizes. 
 
The slope of these regression lines might have clinical significance in determining the 
benefits of upsizing any particular valve in a patient. The steeper slope of the ATS AP 
valve compared with the CarboMedics Top Hat valve, for example, would yield a greater 
increase in GOA if upsizing is done. Our findings show that valves with the steepest 
slope on regression analysis provide the greatest increase in GOA with increasing valve 
size. 
 
Valve sizers have a built-in safety margin of 0.5 to 0.8 mm to minimize the chances of a 
prosthesis not seating correctly after sutures have been placed. The safety margin is 
required because of the manufacturer’s tolerance of ± 0.5 mm for the external diameter, 
which varies as a result of construction of individual sewing rings. This safety margin 
might be exaggerated in supra-annular valves, the sizers of which are sometimes more 
bulky, making it more difficult to place them in a small or heavily calcified narrow aorta. 
The differences seen in these data reflect the ability or inability to place the valve sizer 
into the aortic annulus. During this study, it became apparent that sizing an aortic annulus 
for supra-annular valves was often hampered by the construction of the valve sizers and 
ability to navigate a narrow or calcified aorta. These sizers are provided by the 
manufacturers and recommended for use during implantation; however, some sizers do 
not bear a resemblance to their corresponding prosthetic valve or the true shape of the 
aortic annulus. 
 
Some surgeons deviate from the practice of using the valve-specific sizers to choose a 
valve size in the operating room. These surgeons might be taking advantage of the built-
in safety margin, routinely upsizing and sometimes implanting a valve with a 
corresponding sizer that might not fit into the annulus. 
 
The results of future endeavors, including transapical and transfemoral AVR, will 
ultimately be judged by the ability to implant a prosthesis that results in adequate relief of 
aortic stenosis. Determination of pressure and flow dynamics for the 8 valves is this study 
under controlled conditions with a pulse duplicator might further elucidate the valve-
dependent relationship between GOA and EOA and help to guide future investigations 
into valve replacement strategies. 
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FIGURES and TABLES 
 
Figure 1.  
Number of subjects at each measured annular diameter (n = 66). 
 
 
 
 
 
 
Figure 2.  
Mean deviation of number label from measured annular diameter with standard deviation 
error bars in 5 mechanical valves (top) and 3 stented tissue valves (bottom). Asterisks 
indicate statistically significant deviation from the number label compared with the 
measured annular diameter (n = 66 
 
 
 Figure 3.  
Regression analysis for the 3 different valve types: bioprosthetic, supra-annular 
mechanical, and intra-annular mechanical aortic valves (n = 66). Measured annular area 
is the largest standard sizer that could fit into the annulus (in square centimeters). 
Corresponding annular diameter is the diameter of this sizer in millimeters. 
 
 
 
 
 
Figure 4.  
Relationship between the geometric orifice area and measured annular area in 3 stented 
bioprosthetic valves. Lines depict regression analysis (n = 66). Measured annular area is 
the largest standard sizer that could fit into the annulus (in square centimeters). 
Corresponding annular diameter is the diameter of this sizer in millimeters. 
 
 
 
 
Figure 5.  
Relationships between geometric orifice area and measured annular area in 5 mechanical 
valves. Lines depict regression analysis (n = 66). Measured annular area is the largest 
standard sizer that could fit into the annulus (in square centimeters). Corresponding 
annular diameter is the diameter of this sizer in millimeters. 
 
  
 
Table 1.  
Background characteristics of 66 study subjects 
 
Characteristic No. (%) or mean ± SD No. (%) No. (%) 
Male sex 33 (50%)   
Female sex 33 (50%)   
Age (y) 65 ± 16   
Race    
 White 35 (53%)   
 Black 25 (38%)   
 Hispanic 3 (5%)   
Characteristic No. (%) or mean ± SD No. (%) No. (%) 
 Other 3 (5%)   
Weight (kg) 90.9 ± 29.5   
Body surface area (m2) 2.04 ± 0.36   
Heart weight (g) 537.7 ± 185.3   
Bicuspid valve 1 (1.5%)   
Degree of calcification None to mild Mild to moderate Moderate to severe 
Aortic calcification 51 (77%) 14 (21%) 1 (1.5%) 
Leaflet calcification 50 (75%) 15 (22%) 1 (1.5%) 
Annular calcification 45 (68%) 21 (31%) 0 (0.0%) 
SD, Standard deviation. 
 
